Compex 3 Professional (CefarCompex Medical AB) stimulator
DeviceNMES
NCT Number: NCT02391103
The purposes of this study are 1) to determine whether neuromuscular electrical stimulation (NMES) is effective in preventing loss of muscle mass and strength and 2) to observe the time variation of MLT and strength from preoperative day to hospital discharge.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
In the amendment of June 2011, a twofold study setting was defined in order to recruit patients not only before, but also after cardiothoracic surgery. In sample A, patients were recruited before surgery. In sample B, patients were recruited after surgery. On postoperative day 1, randomization was performed for sample A and B separately. To ensure balance of the NMES and control groups with respect to disease severity, randomization was stratified by the SAPS II score on the first postoperative day. In the intervention group, the anterior muscles of both thighs were electrically stimulated from the first postoperative day until ICU discharge for a maximum of 14 days. In the control group, the electrodes were applied, but no electricity was delivered.The primary outcomes muscle layer thickness (MLT) and muscle strength were assessed from the first postoperative day to ICU discharge and at hospital discharge. All patients in sample A had an additional assessment of MLT and strength before surgery.
All data are analyzed according to the intention-to-treat principle with no imputation for any missing data. Linear mixed models are used to account for the repeated measurements per patient and to determine any fixed effects on MLT and MRC score.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
NMES
no electricity applied
Time frame: on preoperative day, from postoperative day 1 onwards every other ICU day for the duration of the ICU stay (expected average of ICU stay: 7 days) and at day of hospital discharge (expected average of hospital stay: 20 days)
Muscle layer thickness of the anterior muscles of the thigh using two-dimensional B-mode ultrasound
Time frame: on preoperative day, from postoperative day 1 onwards every day for the duration of the ICU stay (expected average of ICU stay: 7 days), at day of hospital discharge (expected average of hospital stay: 20 days)
Muscle strength using Medical Research Council (MRC) score and hand dynamometry
Time frame: on preoperative day, on day of ICU discharge (expected average of ICU stay: 7 days), on day of hospital discharge (expected average of hospital stay: 20 days)
JAGS score
Time frame: on preoperative day, on day of hospital discharge (expected average of hospital stay: 20 days)
Timed Get Up and Go test
Time frame: on preoperative day, on day of hospital discharge (expected average of hospital stay: 20 days)
Functional Independance Measure (FIM) score
Time frame: on preoperative day, on day of hospital discharge (expected average of hospital stay: 20 days)
12-item Short Form Health Survey (SF-12)
Medical University of Vienna
Other
Effects of Neuromuscular Electrical Stimulation on Muscle Mass and Strength in Critically Ill Patients After Cardiothoracic Surgery. An Ultrasound-Based Randomized Controlled Trial
Acronym: Catastim 2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05838911
Chronic Disease, Chronic Obstructive Lung Disease
Qina, Egypt
View Trial DetailsNCT03890250
Idiopathic Pulmonary Fibrosis, Lung Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05465291
ICU Acquired Muscle Weakness, Neuromuscular Electrical Stimulation
Damanhur, Beheira, Egypt
View Trial DetailsNCT01687361
Neuromuscular Electrical Stimulation
Marseille, France
View Trial Details